Similar articles

• Aseptic processing contamination case studies and the pharmaceutical quality system.

  Friedman RL. Friedman RL. PDA J Pharm Sci Technol. 2005 Mar-Apr;59(2):118-26. PDA J Pharm Sci Technol. 2005. PMID: 15971544
• Quality Assurance and Quality Control, Part 2.

  Akers MJ. Akers MJ. Int J Pharm Compd. 2015 May-Jun;19(3):215-21. Int J Pharm Compd. 2015. PMID: 26714362 Review.
• Reverse osmosis as a means of water for injection production: a response to the position of the European Medicines Agency.

  Meltzer TH, Livingston RC, Madsen RE, Jornitz MW, Johnson RM, Mittelman MW. Meltzer TH, et al. PDA J Pharm Sci Technol. 2009 Jan-Feb;63(1):1-7. PDA J Pharm Sci Technol. 2009. PMID: 19455937 No abstract available.
• Risk reduction in biotherapeutic products.

  Ill CR, Dehghani H. Ill CR, et al. Curr Opin Drug Discov Devel. 2009 Mar;12(2):296-304. Curr Opin Drug Discov Devel. 2009. PMID: 19333875 Review.
• Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.

  Allison G, Cain YT, Cooney C, Garcia T, Bizjak TG, Holte O, Jagota N, Komas B, Korakianiti E, Kourti D, Madurawe R, Morefield E, Montgomery F, Nasr M, Randolph W, Robert JL, Rudd D, Zezza D. Allison G, et al. J Pharm Sci. 2015 Mar;104(3):803-12. J Pharm Sci. 2015. PMID: 25830179 Review.